Suppression of keratinocyte growth and differentiation by transforming growth factor beta1 involves multiple signaling pathways
- PMID: 11180003
- DOI: 10.1046/j.1523-1747.2001.01243.x
Suppression of keratinocyte growth and differentiation by transforming growth factor beta1 involves multiple signaling pathways
Abstract
Transforming growth factor beta1 treatment of keratinocytes results in a suppression of differentiation, an induction of extracellular matrix production, and a suppression of growth. In this study we utilized markers specific for each of these functions to explore the signaling pathways involved in mediating these transforming-growth-factor-beta1-induced activities. In the first instance, we found that the induction of extracellular matrix production (characterized by 3TP-Lux reporter activity) was induced in both keratinocytes and a keratinocyte-derived carcinoma cell line, SCC25, in a dose-dependent manner. Furthermore, transforming growth factor beta1 also suppressed the differentiation-specific marker gene, transglutaminase type 1, in both keratinocytes and SCC25 cells. In contrast, transforming growth factor beta1 inhibited proliferation of keratinocytes but did not cause growth inhibition in the SCC25 cells. Transforming-growth-factor-beta1-induced growth inhibition of keratinocytes was characterized by decreases in DNA synthesis, accumulation of hypophosphorylated Rb, and the inhibition of the E2F:Rb-responsive promoter, cdc2, and an induction of the p21 promoter. When the negative regulator of transforming growth factor beta1 signaling, SMAD7, was overexpressed in keratinocytes it could prevent transforming-growth-factor-beta1-induced activation of the 3TP-Lux and the p21 promoter. SMAD7 could also prevent the suppression of the transglutaminase type 1 by transforming growth factor beta1 but it could not inhibit the repression of the cdc2 promoter. These data indicate that the induction of 3TP-Lux and p21 and the suppression of transglutaminase type 1 are mediated by a different proximate signaling pathway to that regulating the suppression of the cdc2 gene. Combined, these data indicate that the regulation of transforming growth factor beta1 actions are complex and involve multiple signaling pathways.
Similar articles
-
Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor beta autoinduction: a negative feedback mechanism for keratinocyte growth.J Invest Dermatol. 2003 Jun;120(6):1030-7. doi: 10.1046/j.1523-1747.2003.12239.x. J Invest Dermatol. 2003. PMID: 12787131
-
Modulation of proliferation-specific and differentiation-specific markers in human keratinocytes by SMAD7.Exp Cell Res. 2004 Apr 1;294(2):356-65. doi: 10.1016/j.yexcr.2003.12.005. Exp Cell Res. 2004. PMID: 15023526
-
Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation.Endocrinology. 2000 Dec;141(12):4728-35. doi: 10.1210/endo.141.12.7848. Endocrinology. 2000. PMID: 11108288
-
Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.Cancer Res. 2003 Nov 15;63(22):7760-8. Cancer Res. 2003. PMID: 14633701
-
Transforming growth factor regulation of keratinocyte growth.Recent Results Cancer Res. 1993;128:15-29. doi: 10.1007/978-3-642-84881-0_2. Recent Results Cancer Res. 1993. PMID: 8356316 Review. No abstract available.
Cited by
-
Development of an in vitro carcinogenesis model of human papillomavirus-induced cervical adenocarcinoma.Cancer Sci. 2022 Mar;113(3):904-915. doi: 10.1111/cas.15246. Epub 2021 Dec 30. Cancer Sci. 2022. PMID: 34932848 Free PMC article.
-
Platelet-derived transforming growth factor-β1 promotes keratinocyte proliferation in cutaneous wound healing.J Tissue Eng Regen Med. 2020 Apr;14(4):645-649. doi: 10.1002/term.3022. Epub 2020 Mar 5. J Tissue Eng Regen Med. 2020. PMID: 32068954 Free PMC article.
-
8-Cl-Adenosine enhances 1,25-dihydroxyvitamin D3-induced growth inhibition without affecting 1,25-dihydroxyvitamin D3-stimulated differentiation of primary mouse epidermal keratinocytes.BMC Pharmacol. 2004 Jul 27;4:13. doi: 10.1186/1471-2210-4-13. BMC Pharmacol. 2004. PMID: 15279680 Free PMC article.
-
Primary Extracellular Matrix Enables Long-Term Cultivation of Human Tumor Oral Mucosa Models.Front Bioeng Biotechnol. 2020 Dec 4;8:579896. doi: 10.3389/fbioe.2020.579896. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 33344431 Free PMC article.
-
Transforming growth factor-beta1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system.Cancer Immunol Immunother. 2005 Sep;54(9):898-906. doi: 10.1007/s00262-004-0652-3. Epub 2005 Mar 18. Cancer Immunol Immunother. 2005. PMID: 15776284 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous